Ernexa Therapeutics (ERNAW) Preferred Dividend Payments (2018 - 2026)

Ernexa Therapeutics (ERNAW) has 7 years of Preferred Dividend Payments data on file, last reported at $8000.0 in Q4 2025.

• Quarterly Preferred Dividend Payments changed 0.0% year-over-year to $8000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $24000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $16000.0, changed 0.0% from the prior year.
• Preferred Dividend Payments held at $8000.0 in Q4 2025, from $8000.0 in the prior quarter.
• In the past five years, Preferred Dividend Payments ranged from a high of $8000.0 in Q2 2021 to a low of $8000.0 in Q2 2021.
• A 5-year average of $8000.0 and a median of $8000.0 in 2021 frame the typical range for Preferred Dividend Payments.
• The widest YoY moves for Preferred Dividend Payments: up 0.0% in 2022, down 0.0% in 2022.
• Tracing ERNAW's Preferred Dividend Payments over 5 years: stood at $8000.0 in 2021, then changed by 0.0% to $8000.0 in 2022, then changed by 0.0% to $8000.0 in 2023, then changed by 0.0% to $8000.0 in 2024, then changed by 0.0% to $8000.0 in 2025.
• The last three Preferred Dividend Payments figures came in at $8000.0 (Q4 2025), $8000.0 (Q2 2025), and $8000.0 (Q4 2024), per Business Quant data.